24/7 Market News Snapshot 13 February, 2025 – P3 Health Partners Inc. Common Stock (NASDAQ:PIII)
DENVER, Colo., 13 February, 2025 (247marketnews.com) – (NASDAQ:PIII) are discussed in this article.
P3 Health Partners Inc. (NASDAQ:PIII), a pioneer in patient-centered population health management, is experiencing a noteworthy surge in market performance, currently trading at $0.240, reflecting an 18.23% increase from the previous session’s closing price of $0.203. This upward trend is accompanied by a trading volume of 5.08 million shares, indicating a significant uptick in investor interest. Analysts are urged to observe support levels around $0.203 and resistance at $0.250 as the stock exhibits considerable volatility and activity.
In tandem with its impressive market performance, P3 has articulated a robust financial strategy, projecting revenues between $1.350 billion and $1.500 billion by 2025. This ambitious guidance is complemented by a forecasted Adjusted EBITDA ranging from -$35 million to $5 million. CEO Aric Coffman noted that the Company’s proactive growth initiatives are expected to generate over $130 million in EBITDA growth and are progressing on schedule.
Coffman reaffirmed P3’s commitment to its foundational business model, which prioritizes enhancing care value for primary care partners, payers, and patients. He stated, “Our business model remains fundamentally strong as we continue to drive value across our network. We expect to issue comprehensive 2025 guidance following the release of our fourth quarter 2024 earnings.”
Moreover, P3 is in discussions with its largest shareholder regarding a proposed financing transaction, potentially securing an additional $30 million in unsecured promissory notes and warrants. This financing is contingent upon approval by a committee of independent directors and completion of requisite documentation, reflecting the Company’s dedication to upholding corporate governance.
As P3 Health Partners advances its strategic objectives, stakeholders can anticipate promising developments leading to its profitability goal in 2025, with further financial insights to be revealed in upcoming earnings announcements.
Related news for (PIII)
- P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction
- p3 health partners names leif pedersen new chief financial officer
- P3 Health Partners Enters $42.2 M Private Placement
- P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference